To Evaluate the Safety of SG2918 in Patients With Relapsed/Refractory Multiple Myeloma
Clinical trial NCT07454187 · RECRUITING
Trial details
- NCT number
- NCT07454187
- Sponsor
- Hangzhou Sumgen Biotech Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-16
- Primary completion
- 2027-09-30
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.